Data as of Dec 17
| +5.90 / +3.02%|
The 3 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 269.00, with a high estimate of 290.00 and a low estimate of 263.00. The median estimate represents a +33.60% increase from the last price of 201.34.
The current consensus among 5 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.